Medical Crossfire Debate: Is Genetic Susceptibility Panel Testing For Breast Cancer Ready For Prime Time | Latest News RSS feed
Medical Crossfire Debate: Is Genetic Susceptibility Panel Testing For Breast Cancer Ready For Prime Time - Latest News
‘Medical Crossfire Debate’: Is Genetic Susceptibility Panel Testing for Breast Cancer Ready for Prime Time?
MIAMI BEACH—Genetic tests for breast cancer susceptibility that go beyond BRCA1/2 mutations are either a very bad idea or an idea whose time has come, depending on which speaker you listened to in a “ ... read more
Dr. Hugh Sampson
Dr. Hugh Sampson is an allergist-immunologist in New York, New York and is affiliated with Mount Sinai Hospital. He received his medical degree from University at Buffalo, School of Medicine and Biome... read more
Cervical Cancer: Late Toxicities Trend Lower with IMRT
SAN ANTONIO—The use of intensity-modulated radiation therapy (IMRT) has increased dramatically over the past decade, and although the technique requires more time, effort ... Phase III PARCER trial in ... read more